Literature DB >> 361575

Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages.

F J Swenson, T R Kozel.   

Abstract

Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated mouse peritoneal macrophages was studied. Thioglycolate-activated macrophages exhibited a lower percent phagocytosis than did normal macrophages. Differences in phagocytosis could not be attributed to differences in macrophage viability, minor variations in the concentration of adherent macrophages, or a general depression in activated macrophage phagocytosis. Thioglycolate-activated macrophages required heat-labile opsonins for optimal phagocytosis of non-encapsulated cryptococci, whereas nonactivated macrophages did not require heat-labile opsonins for phagocytosis of the yeast. Both types of macrophages exhibited similar sensitivity to the phagocytosis-inhibiting properties of cryptococcal polysaccharide. The results show that depletion of heat-labile opsonins from serum or inactivation of yeast-bound, heat-labile opsonins by polysaccharide cannot account for the phagocytosis-inhibiting properties of cryptococcal polysaccharide.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361575      PMCID: PMC422057          DOI: 10.1128/iai.21.3.714-720.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Macrophage activation in vivo and in vitro.

Authors:  B Morland; G Kaplan
Journal:  Exp Cell Res       Date:  1977-09       Impact factor: 3.905

2.  "Macrophage activation" imperfect terminology hiding imperfect knowledge.

Authors:  J Hamburger
Journal:  Ann Immunol (Paris)       Date:  1977 Apr-Jun

3.  Decreased phagocytosis by peritoneal macrophages from BCG-treated mice: induction of the phagocytic defect in normal macrophages with BCG in vitro.

Authors:  C F Nathan; W D Terry
Journal:  Cell Immunol       Date:  1977-03-15       Impact factor: 4.868

4.  Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.

Authors:  T R Kozel; R P Mastroianni
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

5.  Effect of human monocytes and macrophages on Trypanosoma cruzi.

Authors:  D M Williams; J S Remington
Journal:  Immunology       Date:  1977-01       Impact factor: 7.397

6.  Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

Authors:  T R Kozel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

7.  Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages.

Authors:  C F Nathan; W D Terry
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

8.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

9.  Elastase secretion by stimulated macrophages. Characterization and regulation.

Authors:  Z Werb; S Gordon
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

10.  Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross-immunity on challege in vivo.

Authors:  R Hoff
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

View more
  11 in total

1.  Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.

Authors:  R Blackstock; J W Murphy
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans.

Authors:  Kerstin Voelz; David A Lammas; Robin C May
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

3.  Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells.

Authors:  T R Kozel; A Tabuni; B J Young; S M Levitz
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  In vitro binding of natural killer cells to Cryptococcus neoformans targets.

Authors:  N Nabavi; J W Murphy
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  Cryptococcus neoformans: in vivo protection of mice by pretreatment with pyran copolymer.

Authors:  R A Fromtling; H J Shadomy; A M Kaplan
Journal:  Mycopathologia       Date:  1984-03-15       Impact factor: 2.574

6.  Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells.

Authors:  M R Hidore; J W Murphy
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

7.  Studies of phagocytic and killing activities of alveolar macrophages in patients with sarcoidosis.

Authors:  P Orosi; K Nugent
Journal:  Lung       Date:  1993       Impact factor: 2.584

8.  Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

9.  Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.

Authors:  T R Kozel; T G McGaw
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

10.  Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.

Authors:  T R Kozel; J L Follette
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.